A Saklamaz1, B Uyar2, M Yalcin3, H Cengiz4. 1. Department of Endocrinology and Metabolism, Medical Faculty, Sifa University, Izmir, Turkey. 2. Department of Dermatology, Medical Faculty, Sifa University, Izmir, Turkey. 3. Department of Internal Medicine, Medical Faculty, Sifa University, Izmir, Turkey. 4. Department of Biostatistics, Medical Faculty, Sifa University, Izmir, Turkey.
Abstract
BACKGROUND: Isotretinoin (Iso) in acne treatment may cause dyslipidemia and increase in liver enzymes. Moreover, its effect on lipid and glucose metabolism may induce atherosclerotic complications. The aim of this study was to evaluate carotid intima-media thickness (CIMT), osteopontin (OPN), lipid, high sensitive C-reaktive protein (hs-CRP) levels, and insulin resistance (HOMA-IR) in acne patients before and after Iso treatment. MATERIALS: Twenty-one acne patients were treated with Iso (0.5-0.8 mg/kg) for four months. Blood tests for lipid profile, fasting glucose, liver enzymes, OPN, HOMA-IR, hs-CRP and CIMT measurements were performed before and after Iso treatment. Serum levels of OPN and, hs-CRP were measured by ELISA and particle-enhanced turbidimetric immunoassay respectively. RESULTS: Iso treatment significantly increased lipid levels, CIMT (0.60-0.74 mm; p ˂0.001); whereas it non-significantly increased HOMA-IR (0.91-1.87; p =0.70), OPN (4.32-5.44 ng/ml; p =0.27), and hs-CRP (0.08-0.09 mg/dl; p =0.88) levels. There was no correlation between OPN and CIMT (p =0.77). CONCLUSION: Isotretinoin treatment for four months significantly increased CIMT in acne patients. Hippokratia 2016, 20(1): 14-18.
BACKGROUND:Isotretinoin (Iso) in acne treatment may cause dyslipidemia and increase in liver enzymes. Moreover, its effect on lipid and glucose metabolism may induce atherosclerotic complications. The aim of this study was to evaluate carotid intima-media thickness (CIMT), osteopontin (OPN), lipid, high sensitive C-reaktive protein (hs-CRP) levels, and insulin resistance (HOMA-IR) in acnepatients before and after Iso treatment. MATERIALS: Twenty-one acnepatients were treated with Iso (0.5-0.8 mg/kg) for four months. Blood tests for lipid profile, fasting glucose, liver enzymes, OPN, HOMA-IR, hs-CRP and CIMT measurements were performed before and after Iso treatment. Serum levels of OPN and, hs-CRP were measured by ELISA and particle-enhanced turbidimetric immunoassay respectively. RESULTS:Iso treatment significantly increased lipid levels, CIMT (0.60-0.74 mm; p ˂0.001); whereas it non-significantly increased HOMA-IR (0.91-1.87; p =0.70), OPN (4.32-5.44 ng/ml; p =0.27), and hs-CRP (0.08-0.09 mg/dl; p =0.88) levels. There was no correlation between OPN and CIMT (p =0.77). CONCLUSION:Isotretinoin treatment for four months significantly increased CIMT in acnepatients. Hippokratia 2016, 20(1): 14-18.
Entities:
Keywords:
Isotretinoin; carotid intima-media thickness; homeostasis model assessment of insulin resistance; osteopontin
Authors: Young Pil Wang; Misun Choe; Si Young Choi; Ung Jin; Chi Kyung Kim; Eun Joo Seo; Il Jin Cho; Chan Beom Park Journal: J Invest Surg Date: 2009 Mar-Apr Impact factor: 2.533
Authors: Christian Herdeg; Martin Oberhoff; Andreas Baumbach; Stephen Schroeder; Martin Leitritz; Andreas Blattner; Dorothea I Siegel-Axel; Christoph Meisner; Karl R Karsch Journal: Cardiovasc Res Date: 2003-02 Impact factor: 10.787